115 related articles for article (PubMed ID: 1758549)
1. Aluminum and parathyroid hormone concentrations in insulin-dependent diabetics on long-term hemodialysis.
Seidl K; Mrzljak V; Pavlović D; Romić Z; Granić M; Rocić B
Nephron; 1991; 59(3):502-3. PubMed ID: 1758549
[No Abstract] [Full Text] [Related]
2. Comparison of 1 alpha-OH-vitamin D3 and high doses of calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in patients on maintenance dialysis.
Morinière P; Fournier A; Leflon A; Hervé M; Sebert JL; Grégoire I; Bataille P; Guéris J
Nephron; 1985; 39(4):309-15. PubMed ID: 3982576
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
Rao DS; Shih MS; Mohini R
N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
Bellazzi R; Romanini D; Bacchella L; Nai M; Aprile C; Santagostino M; De Vincenzi A
Nephron; 1991; 57(3):273-82. PubMed ID: 2017266
[TBL] [Abstract][Full Text] [Related]
6. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?
Friga V; Linos A; Linos DA
Nephron; 1997; 75(1):48-53. PubMed ID: 9031270
[TBL] [Abstract][Full Text] [Related]
7. [Long-term results of surgical treatment of secondary hyperparathyroidism in patients using a program hemodialysis].
Evmenova TD; Liamina LG
Vestn Khir Im I I Grek; 2014; 173(6):52-3. PubMed ID: 25823312
[TBL] [Abstract][Full Text] [Related]
8. Diminished parathyroid gland responsiveness to hypocalcemia in diabetic patients with uremia.
Heidbreder E; Götz R; Schafferhans K; Heidland A
Nephron; 1986; 42(4):285-9. PubMed ID: 3960240
[TBL] [Abstract][Full Text] [Related]
9. [Radioimmunologic determination of circulating parathyroid hormone in patients with primary and secondary hyperparathyroidism].
Lo Giudice C; Cascone C; Manente P; Gasparoni P; De Luca M; Rota G; Conte N
Minerva Med; 1982 Dec; 73(48):3425-8. PubMed ID: 7177469
[TBL] [Abstract][Full Text] [Related]
10. [Clinical picture and treatment results in patients with secondary hyperparathyroidism].
Bogomolov NI; Pakhol'chuk PP; Prokhorov NB
Vestn Khir Im I I Grek; 2014; 173(6):50-1. PubMed ID: 25823311
[TBL] [Abstract][Full Text] [Related]
11. [Secondary hyperparathyroidism in patients on long-term hemodialysis].
Janda J
Zentralbl Allg Pathol; 1986; 132(5-6):523-31. PubMed ID: 3564736
[TBL] [Abstract][Full Text] [Related]
12. Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
Docci D; del Vecchio C; Salvi P; Turci F; Salvi G; Cenciotti L; Pretolani E
Clin Nephrol; 1985 Feb; 23(2):68-73. PubMed ID: 3987101
[TBL] [Abstract][Full Text] [Related]
13. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
[No Abstract] [Full Text] [Related]
14. [Cimetidine in the treatment of secondary hyperparathyroidism in uremia treated with hemodialysis].
Antonucci F; Gropuzzo M; Messa PG; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Mioni G
Minerva Med; 1985 Mar; 76(9-10):403-6. PubMed ID: 3885074
[No Abstract] [Full Text] [Related]
15. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients.
Meakins JL; Milne CA; Hollomby DJ; Goltzman D
Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120
[TBL] [Abstract][Full Text] [Related]
16. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous remission of severe hyperparathyroidism with normalization of the reversed whole PTH/intact PTH ratio in a haemodialysis patient.
Komaba H; Takeda Y; Abe T; Komaba K; Otsuki N; Nibu K; Umezu M; Fukagawa M
Nephrol Dial Transplant; 2008 May; 23(5):1760-2. PubMed ID: 18079147
[No Abstract] [Full Text] [Related]
18. Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism.
Vulpio C; Bossola M; Di Stasio E; Pepe G; Nure E; Magalini S; Agnes S
Clin Biochem; 2016 May; 49(7-8):538-43. PubMed ID: 26800781
[TBL] [Abstract][Full Text] [Related]
19. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
[TBL] [Abstract][Full Text] [Related]
20. Insulin hypersecretion in patients on chronic hemodialysis. Role of parathyroids.
Lindall A; Carmena R; Cohen S; Comty C
J Clin Endocrinol Metab; 1971 May; 32(5):653-8. PubMed ID: 5577883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
